Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection) recall — Class I (D-0649-2024) · pharmaranks
Class IOngoing
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection) recall
FDA recall D-0649-2024 · initiated Aug 1, 2024
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Details
Product
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04
Recalling company
Baxter Healthcare Corporation
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Aug 1, 2024
FDA report date
Sep 11, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.